SCHEMBL25769006

SCHEMBL25769006

CCC(C(=O)N1CCC[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)c1cc(C)no1

nearest known ligand 0.77

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ VHL P40337 20/20 0.77
▸ ELOC Q15369 6/20 0.56
▸ ELOB Q15370 6/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25769070 1.00 VHL (0.77) VHLELOCELOB
SCHEMBL25773041 0.94 VHL (0.70) VHLELOCELOB
SCHEMBL25110722 0.91 VHL (0.65) VHLELOCELOB
SCHEMBL25768945 0.91 VHL (0.76) VHLELOCELOB
SCHEMBL25768926 0.91 VHL (0.76) VHLELOCELOB
SCHEMBL23986371 0.90 VHL (0.77) VHLELOCELOB
SCHEMBL23986466 0.90 VHL (0.77) VHLELOCELOB
SCHEMBL25768983 0.90 VHL (0.77) VHLELOCELOB
SCHEMBL25772852 0.89 VHL (0.63) VHLELOCELOB
SCHEMBL18063686 0.87 VHL (1.00) VHLELOCELOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203030-A1 COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS ARVINAS OPERATIONS, INC. 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203030-A1 COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS VHL, MDM2, XIAP VHL 1/4885ELOC 203/4885ELOB 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback